Ray-Ban maker EssilorLuxottica has agreed to acquire Signifeye, a Belgian ophthalmology network with 15 eye centres and clinics. The acquisition will expand EssilorLuxottica’s eye care presence in Europe.
Tertianum, Switzerland’s largest for-profit nursing home group, is increasing its market share and dominance in the sector by acquiring pan-European French group emeis’ Swiss branch, Senevita, currently the number two. The Swiss competition authority has already given the deal the go-ahead.
2025 has been a strong year overall for healthcare investments. In this interview, HBI speaks to Amit Karna, Partner at Keensight Capital, a European growth buyout investor.
Skin Analytics is a UK company that has developed an AI-based software tool to analyse whether patients with skin lesions have cancer. In a conversation with HBI, the company’s CEO, Neil Daly, explained how AI tools need to be able to make accurate clinical decisions autonomously, without human input, in order to provide an efficiency benefit to the healthcare system.
UltraGreen.ai, a Singapore-based company that provides an AI-based software platform to aid with fluorescence-guided surgery, has gone public with an IPO on the Singapore Stock Exchange.
Bupa Hong Kong, the Chinese division of multinational health insurer and provider Bupa, is massively expanding its coverage in mainland China, with a new scheme covering 3,600 hospitals across the country. The company is simultaneously expanding coverage to 3,000 ‘service points’ on the island of Hong Kong.
Last week I hosted a webinar for the launch of HBI’s Oncology community developed in partnership with Amethyst Healthcare, a major pan-European radiotherapy group. I was joined by Clarisse Paimes, Global Head of Prevention at AXA, Olivier Cosset, CEO, Amethyst Radiotherapie, France and Justin Hely, CEO, GenesisCare Europe to explore the rising burden of cancer […]
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
